Literature DB >> 14503668

Distribution of perospirone to melanin in pigmented rats.

Yoshiko Mizuno1, Setsuko Komuro, Hiroshi Kanamaru.   

Abstract

Following the administration of [Carbonyl-14C]perospirone ([CO-14C]perospirone) and [isothiazolyl-3-14C]perospirone ([TH-14C]perospirone) to male-pigmented rats at a single oral dose of 10 mg/kg, serum radioactivity reached maxima of 499 ng eq./g and 446 ng eq./g, respectively, at 1 hour, then decreased rapidly to below 2 ng eq./g at 168 hours, and radioactivity in eyeballs reached maxima of 576 ng eq./g and 3449 ng eq./g, respectively, at 24 hours, then decreasing slowly to become 120 ng eq./g and 314 ng eq./g at 26 weeks. Apparent elimination half-lives of radioactivity in eyeballs were 197 and 126 days for [CO-14C]perospirone and [TH-14C]perospirone, respectively. With radioluminograms, radioactivity was detected specifically in the uvea, reaching maxima at 168 hours for [CO-14C]perospirone and at 24 hours for [TH-14C]perospirone. In addition to unchanged compound, many metabolites were found in serum and eyeballs, but those were also detectable in SD albino rats and cynomolgus monkeys. Among radioactive components in eyeballs after administration of [CO-14C]perospirone, ratios of ID-15036 and MX11 followed by unchanged compound and MX9 are high. After administration of [TH-14C]perospirone, ID-11614 accounted for nearly half of the radioactivity. Values decreased in line with radioactivity in eyeballs over time and 26 weeks only a few polar metabolites could be detected.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14503668     DOI: 10.1007/BF03190870

Source DB:  PubMed          Journal:  Eur J Drug Metab Pharmacokinet        ISSN: 0378-7966            Impact factor:   2.441


  9 in total

1.  [On experimental pathology of phenothiazine retinopathy].

Authors:  W Meier-Ruge; A Cerletti
Journal:  Ophthalmologica       Date:  1966       Impact factor: 3.250

2.  Chronic lead administration in neonatal rats: electron microscopy of the retina.

Authors:  R M Santos-Anderson; M O Tso; J J Valdes; Z Annau
Journal:  J Neuropathol Exp Neurol       Date:  1984-03       Impact factor: 3.685

Review 3.  The melanin binding of drugs and its implications.

Authors:  R M Ings
Journal:  Drug Metab Rev       Date:  1984       Impact factor: 4.518

4.  Lack of correlation between melanin affinity and retinopathy in mice and cats treated with chloroquine or flunitrazepam.

Authors:  H Kuhn; P Keller; E Kovács; A Steiger
Journal:  Albrecht Von Graefes Arch Klin Exp Ophthalmol       Date:  1981

5.  A study of the effects of vigabatrin on the central nervous system and retina of Sprague Dawley and Lister-Hooded rats.

Authors:  W H Butler; G P Ford; J W Newberne
Journal:  Toxicol Pathol       Date:  1987       Impact factor: 1.902

Review 6.  Relevance of drug-melanin interactions to ocular pharmacology and toxicology.

Authors:  M M Salazar-Bookaman; I Wainer; P N Patil
Journal:  J Ocul Pharmacol       Date:  1994

7.  Ocular lesions of 6-aminonicotinamide toxicosis in rabbits.

Authors:  J A Render; W W Carlton
Journal:  Vet Pathol       Date:  1985-01       Impact factor: 2.221

Review 8.  Binding of drugs to eye melanin is not predictive of ocular toxicity.

Authors:  B Leblanc; S Jezequel; T Davies; G Hanton; C Taradach
Journal:  Regul Toxicol Pharmacol       Date:  1998-10       Impact factor: 3.271

9.  Pharmacological actions of SM-9018, a new neuroleptic drug with both potent 5-hydroxytryptamine2 and dopamine2 antagonistic actions.

Authors:  A Hirose; T Kato; Y Ohno; H Shimizu; H Tanaka; M Nakamura; J Katsube
Journal:  Jpn J Pharmacol       Date:  1990-07
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.